Movement Alert|Vertex Pharmaceuticals falls 3.01% in Regular Trading, recent executive share sales weigh on sentiment

Market Focus
Nov 20

On November 20, Vertex Pharmaceuticals fell 3.01% in Regular Trading, trading at $520.25 per share, with turnover of $252 million.

The clearest recent catalyst is a cluster of insider sales that has pressured near-term sentiment. The latest disclosed filing showed director Sangeeta N. Bhatia sold 271 shares on November 16 for about $148,470, following an earlier sale by EVP and COO/CFO Charles F. Wagner Jr., who sold 15,286 shares on November 12 for about $8.37 million, and a November 6 sale by CEO Reshma Kewalramani of 11,866 shares for about $6.31 million.

These transactions come after a period of supportive fundamentals and analyst optimism, including positive September data for kidney-disease candidate inaxaplin and a November analyst target increase to $640, but the recent pattern of management selling appears to be outweighing those positives in the current session.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10